Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRONPAD: IV Iron for Preoperative Anemia in PAD
NCT04083755Phase 4Recruiting
- Sponsor
- Biocruces Bizkaia Health Research Institute
- Start
- Aug 2019
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in iron deficiency anemia (IDA) comparing Ferric Carboxymaltose with Standard of Care (2 arms). Primary endpoint: Incidence of blood transfusion. Started Aug 2019; status: recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04083755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04083755.